Hydrocarbon extracted shatter containing cannabis terpenes with 79-82% THC potency; First-of-its-kind product, targeting first-time consumers of cannabis products

LANGLEY, BC , Sept. 3, 2021 /CNW/ - Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (Frankfurt: D2EP) ("Adastra" or the "Company"), a leader in innovative ethnobotanical and cannabis science products, is pleased to announce the acceptance of its first Shatter vaporizer cartridge, under the Phyto Extractions brand. This product line represents a category expansion at the OCS as it is a novel product, offering a convenient-use format to the fast-growing extracts segment of the Canadian adult-use marketplace.

Designed with two strain-specific varieties, Santa Cruz Haze and Jet Fuel, the Shatter vaporizer cartridge product line is a hydrocarbon extracted concentrate containing 3-5 % total cannabis-derived terpenes with 79-82% THC potency. Phyto's iconic Shatter, sought after by retailers and consumers, is formulated and filled for convenient use in a CCELL® 510 thread 1g cartridge.

Donald Dinsmore , COO of Phyto, commented, "The Jet Fuel variety is derived from Powdered Donuts, a Jet Fuel Gelato and Orange Cookies hybrid, while Santa Cruz Haze is derived from Blue Dream. Both strains are BC grown and extracted, creating two unique and satisfying full spectrum experiences derived entirely from cannabis. The products are designed for newcomers to the cannabis market, providing an approachable concentrate for people who have yet to dab or lack the full expertise and equipment. Our innovative Shatter Cartridge will help bring customers along their cannabis journey, from flower to distillate vape, shatter vape, and eventually dabbables like shatter and live resin. There is nothing quite like this in the market, and we believe it addresses an underserved and compelling segment of a rapidly growing consumer base."

The Shatter Cartridge is expected to launch in licensed adult-use retailers in Ontario this fall and next to British Columbia , Alberta , Saskatchewan , and Manitoba .

For the best experience, the Company recommends pairing its cartridges withCCELLL® compatible, low, or multi-temp batteries, such as the M3B model. Concentrates are best consumed at lower temperatures to optimize the flavour profile and effect of the strain.

Founded in 2014, Adastra Holdings Ltd. built a successful reputation as a household name in cannabis concentrates among consumers and retailers alike. Adastra Labs Inc. was founded in 2018 and is an agricultural-scale cannabis extraction, distillation, and product manufacturer, located in Langley, BC . Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing facility, now named Adastra Holdings Ltd., produces and distributes cannabis-derived products designed for medical cannabis and forward-looking therapeutic use.

Known for its renowned cannabis concentrate products, Adastra has now successfully taken the first steps in becoming a licensed cultivator, tester, extractor, and seller of controlled substances, including Psilocybin, Psilocin, MDMA, N, N-Dimethyltryptamine (DMT), 5-MeO-DMT, and LSD by applying for a Controlled Substances Dealer's Licence, which is under review by Health Canada.

As a leading supplier, Adastra Holdings Ltd. currently distributes its product line to 1400+ adult-use retailers and a web-based medical platform, CannMart Inc., seeking to provide consistent, quality concentrate products and alternative treatment options across the country to patients.

Connect with Adastra: Email | Website | Instagram | LinkedIn | Twitter | Facebook

ON BEHALF OF THE BOARD ADASTRA HOLDINGS LTD. (CSE: XTRX)

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect to the Controlled Drugs and Substances Dealer's License; the changing regulations surrounding certain psychedelics and associated treatments; societal acceptance of psychedelic treatments; the ability of the Company to conduct testing, production, or sales of any compounds beyond cannabis; and the ability of the Company to work with partners such as medical doctors, pharmaceutical companies and pharmacies if it is permitted to conduct extraction research and develop psychedelic compounds. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; (iii) changes in regulations surrounding multiple controlled substances; and (iv) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

The Canadian Securities Exchange has not reviewed or approved of any contents of this news release.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2021/03/c0034.html

Q.: My wife inherited a 401(k) from my mom who died recently. Assuming this is a traditional 401(k), you are correct that whatever comes out of the account will be likely be taxable to you. Transfer your wife’s share of the money to an Inherited 401(k) with the company that held your mom’s 401(k).

Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.

Michael Burry, who bet on the collapse of subprime credit, does not hesitate to give his opinion on market developments.

Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Snap Inc. has never been an investor-friendly company as long as those investors weren't their founders, and the parent company of the Snapchat app made that even clearer Thursday.

This money management maven doesn't mince words when it comes to what you shouldn’t be doing with your money.

Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.

Yahoo Finance Editor-in-Chief Andy Serwer discusses Berkshire's stake in Occidental Petroleum and what that indicates to investors.

Fewer are reverting to traditional office jobs, with a growing number seeking nontraditional roles, or even the opportunity to start a new business.

In this article, we discuss the 10 stocks to buy before their earnings reports. If you want to read about some more stocks expected to gain following their quarterly results, go directly to 5 Stocks to Buy Before Their Earnings Reports. With the inflation in the US at a 40-year high and the Federal Reserve […]

Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.

VistaGen Therapeutics Inc (NASDAQ: VTGN) has announced topline results from its PALISADE-1 Phase 3 trial of PH94B for the acute treatment of social anxiety disorder. PH94B did not achieve its primary endpoint, as measured by change from baseline using the Subjective Units of Distress Scale (SUDS) compared to placebo. SUDS rating scale is used to measure the intensity of distress or nervousness in people with social anxiety. Social anxiety disorder affects an estimated 25 million Americans. Altho

Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).

ARKK ETF had a tough day, with nearly all of its holdings aside from Tesla in the red.

Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.

Novavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first commercial product. But the company is still working on younger age group eligibility and boosters with the FDA.

When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).

U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.

(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla

Here’s what you can do if your claim is denied or you’re offered less than you deserve.